CLOSEOUT LETTER
Crop Pharms, LLC
- Recipient:
- Crop Pharms, LLC
United States
- Issuing Office:
United States
Office of Human and Animal Food Operations East | |
VIA UNITED PARCEL SERVICE
DELIVERY SIGNATURE REQUEST
November 7, 2017
Mr. Gregory H. Quinn, President
Crop Pharms, LLC
59 Walnut Lane
Staatsburg, NY 12580
Dear Mr. Quinn:
The Food and Drug Administration has completed an evaluation of your firm's corrective actions in response to our Warning Letter NYK-2013-19, issued on May 24, 2013. Based on our evaluation, it appears that you have addressed the violations contained in this Warning Letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections.
This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means.
Sincerely,
/S/
CDR Catherine Beer
Director, Compliance Branch
Office of Human and Animal Food Operations East Division 1